Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions

Alzheimer’s disease (AD), once considered a rare disease, is now the most common form of dementia in the elderly population. Current drugs (cholinesterase inhibitors and glutamate antagonists) are safe but of limited benefit to most patients, offering symptomatic relief without successful cure of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Miculas, Denisa Claudia, Negru, Paul Andrei, Bungau, Simona Gabriela, Behl, Tapan, Hassan, Syed Shams ul, Tit, Delia Mirela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818415/
https://www.ncbi.nlm.nih.gov/pubmed/36611925
http://dx.doi.org/10.3390/cells12010131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818415/
https://www.ncbi.nlm.nih.gov/pubmed/36611925
http://dx.doi.org/10.3390/cells12010131

Ejemplares similares